"All of these antitrust decisions [related to the two health plan mega-mergers] ...

... are quite different than other policies because basically the law says that a merger should be approved unless they harm the public, whereas usually in political discussion people are talking about the benefits to the people of something. I don't think much of a case has been made that these mergers will benefit the public, but then the law is just to assess whether it will harm the public."

— Paul Ginsburg, Ph.D., director of public policy for the Schaeffer Center for Health Policy and Economics at the University of Southern California, told AIS's Health Plan Week